Prostate cancer is a malignant tumor of the prostate, a gland found only in men. The prostate’s function is to create some of the fluid that insulates the sperm cells found in semen.
Active Surveillance for Prostate Cancer | Charlie's Story
Enrolled in the Active Surveillance program for prostate cancer at Johns Hopkins, Charlie Cronheim has been living with very low risk prostate cancer for 10 years without any surgical intervention.This management option involves careful monitoring to ensure there are no changes in the disease that require attention. The active surveillance program has allowed Charlie to maintain his normal life activities without the side effects of surgery.
MRI Fusion Biopsy | Q&A with Dr. H. Ballentine Carter
Dr. H. Ballentine Carter, a urologic oncologist at Johns Hopkins Hospital, explains the difference between a standard biopsy procedure and a fusion biopsy procedure for the detection of prostate cancer.
This short video will prepare you for what to expect during your stay at the hospital.
Robotic Prostate Surgery | Q&A
Robotic Surgery Director, Dr. Mohamad Allaf, discusses Johns Hopkins' prostatectomy program, including the Brady Urological Institute's robust robotic experience, prostatectomy pioneer Dr. Walsh, and unique post-operative care provided at Hopkins.
Prostate Cancer | Bill’s Story
After being diagnosed with prostate cancer, Bill Shipp, a championship swimmer came to The Johns Hopkins Hospital seeking a second opinion regarding management of his condition. Dr. Mohamad Allaf, Director of Minimally Invasive and Robotic Urologic Surgery and his team performed a radical prostatectomy on Mr. Shipp, clearing his prostate of cancer. Mr. Shipp was back in the pool four weeks after surgery and has completed several swim marathons after recovery.
Are Supplements Good for Prostate Health?
Are Supplements Good for Prostate Health? How can you protect your prostate? Johns Hopkins urologist H. Ballentine Carter offers tips.
What You Need to Know at Every Stage
Prostate Cancer Prevention and Risk Management
- One in six men will be diagnosed with prostate cancer during his lifetime.
- Prostate cancer is the second most common cancer in American men.
- Over 50 percent of prostate cancer deaths are in men diagnosed after the age of 75.
- Early prostate cancer may be present without any symptoms. It can often be detected with screening tests.
- Prostate-specific antigen screening reduces death by approximately 30 percent.
Prostate Cancer Recovery
Many men have concerns about how prostate cancer treatment will affect their quality of life. Thanks to groundbreaking advances in surgical techniques and novel discoveries in the lab, most men find that the side effects are far milder than they had feared. Learn how to manage some of the most common:
Our Multidisciplinary Approach
The Brady Urological Institute works with the Sidney Kimmel Comprehensive Cancer Center in a multidisciplinary approach to ensure the highest quality patient care and innovative research when treating prostate cancer.
Investigators at the Brady Urological Institute are world leaders in prostate cancer research. Explore our latest discoveries and clinical trial opportunities: